You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 6, June 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mushroom-Shaped Choroidal Recurrence of Retinoblastoma 25 Years After Therapy

Arch Ophthalmol. 2002;120:844-846.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

An important method of conservative therapy for retinoblastoma during the past 50 years has been external beam radiotherapy. In general, this modality offers favorable tumor control, but subsequent monitoring for local recurrence and application of salvage therapy have been emphasized. Several authors have observed that recurrence is usually detected within 1 year of therapy.1-2 We report late-onset choroidal recurrence of retinoblastoma 25 years following therapy.

Report of a Case

A 25-year-old Latin American woman noticed sudden, painless visual loss in her only eye on awakening. Visual acuity was hand motions OD; the left eye had been enucleated. She gave a history of bilateral sporadic retinoblastoma diagnosed at age 12 months and managed initially with chemotherapy and cryotherapy to the right eye and enucleation of the left eye. One year later, 2 tumor recurrences were detected at the site of previous cryotherapy scars superiorly and inferonasally, measuring 1.5 x 1.5 x 1.0 mm and 12.0 . . . [Full Text of this Article]


Comment
Corresponding author and reprints: Carol L. Shields, MD, Ocular Oncology Service, Wills Eye Hospital, 900 Walnut St, Philadelphia, PA 19107.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.